Form 4 Filing for COGNITION THERAPEUTICS INC

This filing details transactions by John Brendan Doyle, Chief Financial Officer of COGNITION THERAPEUTICS INC. On December 18, 2025, Mr. Doyle acquired 30,000 shares of Common Stock upon the vesting of performance stock units (PSUs) granted on February 14, 2024. These PSUs represent a contingent right to receive shares upon achieving performance goals, with 50% vesting on December 18, 2025. Following this acquisition, Mr. Doyle directly owns 455,350 shares. Additionally, on the same date, Mr. Doyle disposed of 9,360 shares of Common Stock, valued at $1.50 per share, to cover tax withholding obligations related to the PSU vesting. This disposition resulted in a post-transaction ownership of 445,990 shares.